Optoacoustic imaging firm Seno Medical Instruments is officially launching the now commercially available Imagio breast imaging system at RSNA 2022.
The system uses a combination of noninvasive ultrasound and optoacoustic technology to provide information about breast lesions in real-time. It combines laser optics and grayscale ultrasound to provide fused functional and anatomical breast imaging.
The optoacoustic images provide a unique blood map in and around breast masses, while the ultrasound provides a traditional anatomic image. The system is designed to help radiologists confirm or rule out malignancy of suspicious breast lesions, and it includes the SenoGram artificial intelligence decision-support tool.